RE:Big week...start of news releases?SMMT ...Summit Therapeutics just signed a contract with a Chinese Antibody Research Co that included a $500 million upfront payment and a further $4.5 billion royalty agreement. Summit is presenting at next months JP Morgan conference in San Fransisco alongside IPA.
The Chinese Co is starting Phase 3 trials targeting cancers.
IPA is also targeting cancer and several other major Health conditions. IPA also has partnerships in China and Europe.
Their pipeline can be viewed on their website and tomorrows Conference Call cc will likely shed some new light on these targets. glta
.